Defective Fas ligand production in lymphocytes from MS patients

Beatrice Macchi, Claudia Matteucci, Ugo Nocentini, Santina Tacconi, Veronica Pagnini, Antonio Mastino, Carlo Caltagirone

Research output: Contribution to journalArticle

Abstract

In the present transectional study, Fas ligand (Fas-L) levels, either in membrane or in soluble form, in cells from multiple sclerosis (MS) patients were investigated. Expression of Fas was evaluated after PHA stimulation of peripheral blood mononuclear cells from MS patients with relapsing-remitting or secondary-progressive disease, and in healthy donors. There was statistically significant decreased expression (p = 0.001), as well as release of Fas-L, (p = 0.045) in lymphocytes from MS patients, in comparison with healthy donors. Moreover, levels of Fas-L production were inversely correlated with the EDSS scores of patients in an highly significant way. Impairment of Fas-L release in stimulated PBMC from MS patients might influence the ability to eliminate autoreactive clones in vivo.

Original languageEnglish
Pages (from-to)4113-4116
Number of pages4
JournalNeuroReport
Volume12
Issue number18
Publication statusPublished - Dec 21 2001

Fingerprint

Fas Ligand Protein
Multiple Sclerosis
Lymphocytes
Tissue Donors
Blood Cells
Clone Cells
Membranes

Keywords

  • Apoptosis
  • EDSS
  • Fas ligand
  • Lymphocytes
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Macchi, B., Matteucci, C., Nocentini, U., Tacconi, S., Pagnini, V., Mastino, A., & Caltagirone, C. (2001). Defective Fas ligand production in lymphocytes from MS patients. NeuroReport, 12(18), 4113-4116.

Defective Fas ligand production in lymphocytes from MS patients. / Macchi, Beatrice; Matteucci, Claudia; Nocentini, Ugo; Tacconi, Santina; Pagnini, Veronica; Mastino, Antonio; Caltagirone, Carlo.

In: NeuroReport, Vol. 12, No. 18, 21.12.2001, p. 4113-4116.

Research output: Contribution to journalArticle

Macchi, B, Matteucci, C, Nocentini, U, Tacconi, S, Pagnini, V, Mastino, A & Caltagirone, C 2001, 'Defective Fas ligand production in lymphocytes from MS patients', NeuroReport, vol. 12, no. 18, pp. 4113-4116.
Macchi B, Matteucci C, Nocentini U, Tacconi S, Pagnini V, Mastino A et al. Defective Fas ligand production in lymphocytes from MS patients. NeuroReport. 2001 Dec 21;12(18):4113-4116.
Macchi, Beatrice ; Matteucci, Claudia ; Nocentini, Ugo ; Tacconi, Santina ; Pagnini, Veronica ; Mastino, Antonio ; Caltagirone, Carlo. / Defective Fas ligand production in lymphocytes from MS patients. In: NeuroReport. 2001 ; Vol. 12, No. 18. pp. 4113-4116.
@article{82dd5ac3c94a4d71a0cf4f1cb7d47419,
title = "Defective Fas ligand production in lymphocytes from MS patients",
abstract = "In the present transectional study, Fas ligand (Fas-L) levels, either in membrane or in soluble form, in cells from multiple sclerosis (MS) patients were investigated. Expression of Fas was evaluated after PHA stimulation of peripheral blood mononuclear cells from MS patients with relapsing-remitting or secondary-progressive disease, and in healthy donors. There was statistically significant decreased expression (p = 0.001), as well as release of Fas-L, (p = 0.045) in lymphocytes from MS patients, in comparison with healthy donors. Moreover, levels of Fas-L production were inversely correlated with the EDSS scores of patients in an highly significant way. Impairment of Fas-L release in stimulated PBMC from MS patients might influence the ability to eliminate autoreactive clones in vivo.",
keywords = "Apoptosis, EDSS, Fas ligand, Lymphocytes, Multiple sclerosis",
author = "Beatrice Macchi and Claudia Matteucci and Ugo Nocentini and Santina Tacconi and Veronica Pagnini and Antonio Mastino and Carlo Caltagirone",
year = "2001",
month = "12",
day = "21",
language = "English",
volume = "12",
pages = "4113--4116",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - Defective Fas ligand production in lymphocytes from MS patients

AU - Macchi, Beatrice

AU - Matteucci, Claudia

AU - Nocentini, Ugo

AU - Tacconi, Santina

AU - Pagnini, Veronica

AU - Mastino, Antonio

AU - Caltagirone, Carlo

PY - 2001/12/21

Y1 - 2001/12/21

N2 - In the present transectional study, Fas ligand (Fas-L) levels, either in membrane or in soluble form, in cells from multiple sclerosis (MS) patients were investigated. Expression of Fas was evaluated after PHA stimulation of peripheral blood mononuclear cells from MS patients with relapsing-remitting or secondary-progressive disease, and in healthy donors. There was statistically significant decreased expression (p = 0.001), as well as release of Fas-L, (p = 0.045) in lymphocytes from MS patients, in comparison with healthy donors. Moreover, levels of Fas-L production were inversely correlated with the EDSS scores of patients in an highly significant way. Impairment of Fas-L release in stimulated PBMC from MS patients might influence the ability to eliminate autoreactive clones in vivo.

AB - In the present transectional study, Fas ligand (Fas-L) levels, either in membrane or in soluble form, in cells from multiple sclerosis (MS) patients were investigated. Expression of Fas was evaluated after PHA stimulation of peripheral blood mononuclear cells from MS patients with relapsing-remitting or secondary-progressive disease, and in healthy donors. There was statistically significant decreased expression (p = 0.001), as well as release of Fas-L, (p = 0.045) in lymphocytes from MS patients, in comparison with healthy donors. Moreover, levels of Fas-L production were inversely correlated with the EDSS scores of patients in an highly significant way. Impairment of Fas-L release in stimulated PBMC from MS patients might influence the ability to eliminate autoreactive clones in vivo.

KW - Apoptosis

KW - EDSS

KW - Fas ligand

KW - Lymphocytes

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0035930444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035930444&partnerID=8YFLogxK

M3 - Article

C2 - 11742248

AN - SCOPUS:0035930444

VL - 12

SP - 4113

EP - 4116

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 18

ER -